[Helicobacter pylori eradication therapy for children].
Konno
Mutsuko
M
Department of Pediatrics, Sapporo Kosei General Hospital.
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000658:Amoxicillin / Q000008:administration & dosage; D018798:Anemia, Iron-Deficiency / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002648:Child; D017291:Clarithromycin / Q000008:administration & dosage; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005767:Gastrointestinal Diseases / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D008795:Metronidazole / Q000008:administration & dosage; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives; D010349:Patient Compliance; D054328:Proton Pump Inhibitors; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000382:microbiology; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D008795:Metronidazole; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole